|   |
| Research Topics: |
| INDEX |
| AI-chat 4 |
| PRIME 24 |
| aging 8 |
| brain 6 |
| cancer 8 |
| cognition 5 |
| culture 1 |
| diabetes 2 |
| diagnostics 3 |
| economy 1 |
| genetics 2 |
| gut 1 |
| heart 5 |
| immune 2 |
| microbiome 1 |
| misc 1 |
| nutrition 6 |
| obesity 1 |
| pain 3 |
| politics 2 |
| pollution 2 |
| population 1 |
| practice 1 |
| privacy 1 |
| psychology 2 |
| religion 1 |
| reproduction 2 |
| sleep 2 |
| vaccine 3 |
|
Scanned: 2601 Evaluated: 105 Selected: 42 |
| PRIME   CANCER DIABETES   IMMUNE   NUTRITION   | ||||||||
Aaa23-000 | Berberine as a Therapeutic Strategy for Cancer | |||||||
| Quote: | Berberine is a well-known nutraceutical because of its wide variety of pharmacological activities including: anti-inflammatory, antioxidant, antibacterial, antiparasitic, antifungal, antidiabetic, antihypertensive, anti-obesity, antimicrobial and anticancer. In this article I will summarize the anticancer activities of berberine. How berberine fights cancer | |||||||
| Article: | https://richardgoldberg.substack.com/p/berberine-as-a-therapeutic-strategy | |||||||
| Search Similar: | Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho | |||||||
| CANCER DIAGNOSTICS   | ||||||||
Mca23-026 | A liquid biopsy-centered, pan-cancer, open next generation sequencing panel to support clinical decision-making (LION panel) | |||||||
| Abstract: | https://www.medrxiv.org/content/10.64898/2026.06.05.26354976v1 | |||||||
| Full Text: | https://www.medrxiv.org/content/10.64898/2026.06.05.26354976v1.full-text | |||||||
| Search Similar: | Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho | |||||||
| Search Authors: | Sabrina Feierabend Axel Knstner Michael Forster Theresa Helbing Niklas Gebauer Timo Gemoll Franziska Axt Subbaiah Chary Nimmagadda Lavanya Ranganathan Johanna Schwandt Marilena Heber Silke Szymczak Ina Hohensee Stephanie M. J. Fliedner Florian Scherer Martina Oberlnder Stefanie Derer-Petersen Hauke Busch Nikolas von Bubnoff Eva Dazert, | |||||||
| CANCER REPRODUCTION   | ||||||||
Mge23-022 | Prevalence and Clinical Significance of Adult-Onset Cancer Predisposition Variants in Pediatric Oncology | |||||||
| Quote: | Conclusion In pediatric oncology, most variants in aoCPG are secondary rather than tumor-related findings. Tumor-informed interpretation, beyond variant classification, may improve reporting, counseling, and therapeutic decision-making | |||||||
| Abstract: | https://www.medrxiv.org/content/10.64898/2026.06.07.26354365v1 | |||||||
| Full Text: | https://www.medrxiv.org/content/10.64898/2026.06.07.26354365v1.full-text | |||||||
| Search Similar: | Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho | |||||||
| Search Authors: | Jamie L. Maciaszek Victor Pastor Loyola Taylor Cain Maria Cardenas Patrick R. Blackburn Mark R. Wilkinson Selene C. Koo Chih-Hsuan Wu Cai Li Lu Wang Kim E. Nichols Jeffery M. Klco Mohammad K. Eldomery, | |||||||
| CANCER | ||||||||
Mpt23-022 | Immunohistochemical phenotype is associated with metastatic site in breast cancer: a retrospective pathomorphological study of women from the Lower Aral Sea region, Uzbekistan | |||||||
| Quote: | Conclusions In this regional cohort, the IHC phenotype of breast cancer tracked the anatomical site of metastasis, with an aggressive HER2-driven, hormone-receptor-negative profile concentrated in liver metastases and a hormone-receptor-positive profile in lymph-node metastases. These findings reproduce established organotropism patterns in a previously uncharacterized population and support phenotype-aware, site-specific surveillance together with a low-cost morphological risk score for resource-limited settings. | |||||||
| Abstract: | https://www.medrxiv.org/content/10.64898/2026.06.05.26354969v1 | |||||||
| Full Text: | https://www.medrxiv.org/content/10.64898/2026.06.05.26354969v1.full-text | |||||||
| Search Similar: | Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho | |||||||
| Search Authors: | Adham A. Khodjaniyazov Ruslon R. Rojobov, | |||||||
| CANCER | ||||||||
Sda233-003 | Scientists Shut Down Cancer DNA Repair to Overcome Drug Resistance | |||||||
| Article: | /releases/2026/06/260610003052.htm /releases/2026/06/260610003052.htmhttps://www.sciencedaily.com/releases/2026/06/260610003052.htm | |||||||
| Search Similar: | Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho | |||||||
| CANCER | ||||||||
Sda233-009 | Cancer Patients Found a Simple Way to Stay Mentally Sharp During Chemotherapy | |||||||
| Article: | /releases/2026/06/260608040019.htm https://www.sciencedaily.com/releases/2026/06/260608040019.htm | |||||||
| Search Similar: | Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho | |||||||
| CANCER | ||||||||
Sda233-038 | The Secret Reason Some Cancer Treatments Stop Working | |||||||
| Quote: | Scientists have uncovered a hidden immune system "brake" that may help cancers avoid being destroyed. The molecule, called SLAMF6, weakens the bodys cancer-fighting T cells and can leave them exhausted over time. Researchers developed antibodies that block this brake, allowing immune cells to stay stronger and attack tumors more effectively | |||||||
| Article: | /releases/2026/06/260608040021.htm https://www.sciencedaily.com/releases/2026/06/260608040021.htm | |||||||
| Search Similar: | Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho | |||||||
| PRIME   CANCER | ||||||||
Zzb23-004 | Study Finds Sunscreen Use Linked to Higher Risk of Multiple Skin Cancers | |||||||
| Quote: | A UK Biobank study involving over 470,000 people found that individuals who reported using sunscreen more frequently had substantially higher risk of multiple skin cancers even after researchers accounted for major confounding factors like age, sex, skin type, tanning ability, sunburn history, sunlamp use, and time spent outdoors. | |||||||
| Article: | https://principia-scientific.com/study-finds-sunscreen-use-linked-to-higher-risk-of-multiple-skin-cancers/ | |||||||
| Search Similar: | Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho | |||||||
|
Javilk's Research Links for Week 23 Updated 06/13/2026-02:39:38 AM What interests you? What have you found? Tell me! Drop me a note to subscribe or submit something. |